|
|
Article: Research from N.T. Hong Kong SAR, Department of Biochemistry in the area of Alzheimer disease therapy published.
- Article from:
- Medical Letter on the CDC & FDA
- Article date:
- November 16, 2008
CopyrightCOPYRIGHT 2008 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Fresh data on Alzheimer disease are presented in the report 'Anti-acetylcholinesterase activities of traditional Chinese medicine for treating Alzheimer's disease.' "Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive memory loss and cognitive impairment. It is the most common type of dementia in the aging population due to a severe loss of cholinergic neurons in selected brain area," scientists writing in the journal Chemico-Biological Interactions report (see also Alzheimer Disease Therapy).
"At present, acetylcholinesterase inhibitors (AChEI) are the first group of drugs approved by the FDA to treat mild to moderate ...
Related newspaper, magazine, and journal articles:
|
|
Article: Hong Kong, mainland scientists to set up Chinese ...
Health & Medicine Week;
March 8, 2004 ;
445 words
... ... Researchers hope to sign up Hong Kong and mainland Chinese ... Yeung, a University of Hong Kong spokeswoman. "It ... Parkinson disease and Alzheimer disease, the university said. The University of Hong Kong and China's Central ...
|
|